Publication | Open Access
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
198
Citations
14
References
2010
Year
Hematological MalignancyOncologyImmunologyHematologyMyeloid NeoplasiaLow Dose DexamethasonePharmacotherapyMedicineRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1